Goldman Sachs’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.74M Sell
524,685
-294,164
-36% -$974K ﹤0.01% 3501
2025
Q1
$2.37M Sell
818,849
-57,688
-7% -$167K ﹤0.01% 3247
2024
Q4
$3.12M Buy
876,537
+653,850
+294% +$2.33M ﹤0.01% 3202
2024
Q3
$1.11M Buy
222,687
+108,678
+95% +$541K ﹤0.01% 3697
2024
Q2
$296K Sell
114,009
-412,413
-78% -$1.07M ﹤0.01% 4219
2024
Q1
$2.24M Buy
526,422
+495,923
+1,626% +$2.11M ﹤0.01% 3137
2023
Q4
$61.6K Buy
+30,499
New +$61.6K ﹤0.01% 4523
2023
Q3
Sell
-57,149
Closed -$94.3K 4726
2023
Q2
$94.3K Buy
+57,149
New +$94.3K ﹤0.01% 4574
2022
Q4
Sell
-27,704
Closed -$32K 5149
2022
Q3
$32K Buy
27,704
+13,545
+96% +$15.6K ﹤0.01% 5083
2022
Q2
$9K Sell
14,159
-34,153
-71% -$21.7K ﹤0.01% 5531
2022
Q1
$126K Sell
48,312
-8,995
-16% -$23.5K ﹤0.01% 5240
2021
Q4
$223K Sell
57,307
-15,858
-22% -$61.7K ﹤0.01% 4932
2021
Q3
$319K Buy
73,165
+5,135
+8% +$22.4K ﹤0.01% 4624
2021
Q2
$270K Buy
68,030
+21,204
+45% +$84.2K ﹤0.01% 4757
2021
Q1
$243K Sell
46,826
-4,341
-8% -$22.5K ﹤0.01% 4747
2020
Q4
$274K Sell
51,167
-29,160
-36% -$156K ﹤0.01% 4124
2020
Q3
$390K Buy
80,327
+60,476
+305% +$294K ﹤0.01% 3782
2020
Q2
$96K Buy
+19,851
New +$96K ﹤0.01% 4189
2020
Q1
Sell
-48,336
Closed -$281K 4406
2019
Q4
$281K Buy
48,336
+38,127
+373% +$222K ﹤0.01% 3882
2019
Q3
$32K Buy
+10,209
New +$32K ﹤0.01% 4162
2019
Q2
Sell
-40,160
Closed -$278K 4171
2019
Q1
$278K Buy
40,160
+19,265
+92% +$133K ﹤0.01% 3768
2018
Q4
$132K Sell
20,895
-559
-3% -$3.53K ﹤0.01% 3843
2018
Q3
$376K Buy
+21,454
New +$376K ﹤0.01% 3563